| 摘要 |
<p>There is provided combination products comprising: (a) suplatast, or a pharmaceutica?y-acceptable salt or solvate thereof; and (b) ramatroban, or a pharmaceutically-acceptable salt or solvate thereof. Such combination products find particular utility in the treatment of atherosclerosis and related conditions.</p> |
